Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 Post published:September 11, 2022 Post category:Press Release
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences Post published:September 9, 2022 Post category:Press Release
Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami Post published:September 9, 2022 Post category:Press Release
Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit Post published:September 9, 2022 Post category:Press Release
MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal Post published:September 9, 2022 Post category:Press Release
Small Pharma to Participate in Upcoming September Investor Conferences Post published:September 8, 2022 Post category:Press Release
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History Post published:September 8, 2022 Post category:Press Release
Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors Post published:September 8, 2022 Post category:Press Release
Psyence Group Announces Amendment and Closing of Previously Announced Private Placement Post published:September 8, 2022 Post category:Press Release
atai Life Sciences to Participate in September Investor Events Post published:September 8, 2022 Post category:Press Release